<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32583696</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>907</StartPage><EndPage>919</EndPage><MedlinePgn>907-919</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14737175.2020.1788389</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease that leads to death after a median survival of 36&#xa0;months. The development of an effective treatment has proven to be extremely difficult due to the inadequate understanding of the pathogenesis of ALS. Energy metabolism is thoroughly involved in the disease based on the discoveries of hypermetabolism, lipid/glucose metabolism, the tricarboxylic acid (TCA) cycle, and mitochondrial impairment.</AbstractText><AbstractText Label="AREA COVERED">Many perturbed metabolites within these processes have been identified as promising therapeutic targets. However, the therapeutic strategies targeting these pathways have failed to produce clinically significant results. The authors present in this review the metabolic disturbances observed in ALS and the derived-therapeutics.</AbstractText><AbstractText Label="EXPERT OPINION">The authors suggest that this is due to the insufficient knowledge of the relationship between the metabolic targets and the type of ALS of the patient, depending on genetic and environmental factors. We must improve our understanding of the pathological mechanisms and pay attention to the subtle hidden effects of changing diet, for example, and to use this strategy in addition to other drugs or to use metabolism status to determine subgroups of patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanznaster</LastName><ForeName>Debora</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5911-3120</Identifier><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veyrat-Durebex</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hergesheimer</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vourch</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maillot</LastName><ForeName>Francois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andres</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire de Biochimie et Biologie Mol&#xe9;culaire, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Imaging Laboratory, CNRS, INSERM, Sorbonne University , Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHP, Department of Neurology, Paris ALS Center, Piti&#xe9; Salp&#xea;tri&#xe8;re Hospital , Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Phillipe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit&#xe9; INSERM U1253, &#xe9;quipe, neurog&#xe9;nomique et physiopathologie neuronale, Universit&#xe9; de Tours , Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Neurologie, CHRU de Tours , Tours, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="N">Metabolic Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">TCA cycle</Keyword><Keyword MajorTopicYN="N">metabolic alteration</Keyword><Keyword MajorTopicYN="N">metabolic therapeutics</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32583696</ArticleId><ArticleId IdType="doi">10.1080/14737175.2020.1788389</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>